Literature DB >> 11864679

Intrauterine growth restriction.

Robert Resnik1.   

Abstract

Fetal intrauterine growth restriction presents a complex management problem for the clinician. The failure of a fetus to achieve its growth potential imparts a significantly increased risk of perinatal morbidity and mortality. Consequently, the obstetrician must recognize and accurately diagnose inadequate fetal growth and attempt to determine its cause. Growth aberrations, which are the result of intrinsic fetal factors such as aneuploidy and multifactorial congenital malformations, and fetal infection, carry a guarded prognosis. However, when intrauterine growth restriction is caused by placental abnormalities or maternal disease, the growth aberration is usually the consequence of inadequate substrates for fetal metabolism and, to a greater or lesser degree, decreased oxygen availability. Careful monitoring of fetal growth and well-being, combined with appropriate timing and mode of delivery, can best ensure a favorable outcome. Ultrasound evaluation of fetal growth, behavior, and measurement of impedance to blood flow in fetal arterial and venous vessels form the cornerstone of evaluation of fetal condition and decision making.

Entities:  

Mesh:

Year:  2002        PMID: 11864679     DOI: 10.1016/s0029-7844(01)01780-x

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  130 in total

Review 1.  Calcium channel blockers for potential impaired fetal growth.

Authors:  A M Gülmezoglu; G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  Transcutaneous electrostimulation for suspected placental insufficiency (diagnosed by Doppler studies).

Authors:  A M Gülmezoglu; G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 3.  Plasma volume expansion for suspected impaired fetal growth.

Authors:  A M Gülmezoglu; G J Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  Normal lactational environment restores cardiomyocyte number after uteroplacental insufficiency: implications for the preterm neonate.

Authors:  M Jane Black; Andrew L Siebel; Oksan Gezmish; Karen M Moritz; Mary E Wlodek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-07       Impact factor: 3.619

5.  Obstetric management of IUGR.

Authors:  Mariapia Militello; Elisa Maria Pappalardo; Santina Ermito; Angela Dinatale; Alessandro Cavaliere; Sabina Carrara
Journal:  J Prenat Med       Date:  2009-01

6.  Parenteral administration of L-arginine prevents fetal growth restriction in undernourished ewes.

Authors:  Arantzatzu Lassala; Fuller W Bazer; Timothy A Cudd; Sujay Datta; Duane H Keisler; M Carey Satterfield; Thomas E Spencer; Guoyao Wu
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

7.  Infertility, infertility treatment, and fetal growth restriction.

Authors:  Jin Liang Zhu; Carsten Obel; Bodil Hammer Bech; Jørn Olsen; Olga Basso
Journal:  Obstet Gynecol       Date:  2007-12       Impact factor: 7.661

8.  Poorer maternal diet quality and increased birth weight.

Authors:  Madeline Grandy; Jonathan M Snowden; Janne Boone-Heinonen; Jonathan Q Purnell; Kent L Thornburg; Nicole E Marshall
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-18

9.  Doppler-based fetal heart rate analysis markers for the detection of early intrauterine growth restriction.

Authors:  Lisa Stroux; Christopher W Redman; Antoniya Georgieva; Stephen J Payne; Gari D Clifford
Journal:  Acta Obstet Gynecol Scand       Date:  2017-09-27       Impact factor: 3.636

10.  Stature and status: Height, ability, and labor market outcomes.

Authors:  Anne Case; Christina Paxson
Journal:  J Polit Econ       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.